Clinical Trials
12 trialsNCT06959589 2026-05-11
cruciall
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Enrolling by invitation
NCT06773936 2026-05-06
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
Phase 2 Enrolling by invitation
NCT07062354 2026-05-06
CAPT-HN
SWOG Cancer Research Network
Phase 2 Enrolling by invitation
NCT07550582 2026-04-30
SAVE-GEJ
Peking University People's Hospital
Phase 2 Enrolling by invitation
NCT07441369 2026-04-27
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
Fudan University
Phase 2 Enrolling by invitation
NCT07542262 2026-04-24
NIVO402025
Blokhin's Russian Cancer Research Center
Phase 2 Enrolling by invitation
NCT07550972 2026-04-24
Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
Zhejiang Provincial People's Hospital
Phase 2 Enrolling by invitation
NCT07542158 2026-04-21
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
Phase 2 Enrolling by invitation
NCT07517419 2026-04-08
PIPAC in Gastric Peritoneal Metastasis
Chinese University of Hong Kong
Phase 2 Enrolling by invitation
NCT07517510 2026-04-08
HVA-MPAL
Guangdong Second Provincial General Hospital
Phase 2 Enrolling by invitation
NCT07488572 2026-03-23
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
Sun Yat-sen University
Phase 2 Enrolling by invitation
NCT06650748 2026-03-17
NeoMARS
Peking University
Phase 2 Enrolling by invitation